NDATOPICALSPONGE
Approved
Dec 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PHARMASEAL SCRUB CARE (chlorhexidine gluconate) by Fusion Pharmaceuticals Inc. is clinical pharmacology periogard® (chlorhexidine gluconate oral rinse usp, 0. First approved in 1988.
Drug data last refreshed 20h ago · AI intelligence enriched 23h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PHARMASEAL SCRUB CARE is a topical chlorhexidine gluconate 0.12% oral rinse sponge formulation approved in 1988 for antimicrobial oral care. It works by reducing oral bacteria counts 54-97% through direct topical application and sustained release from oral cavity retention. The drug is indicated for preoperative and perioperative oral antisepsis in surgical and clinical settings.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30); expect team rationalization and transition planning.
Mechanism of Action
CLINICAL PHARMACOLOGY PerioGard® (Chlorhexidine Gluconate Oral Rinse USP, 0.12%) provides antimicrobial activity during oral rinsing. The clinical significance of chlorhexidine gluconate oral rinse's antimicrobial activities is not clear. Microbiological sampling of plaque has shown a general…
Indications
Worked on PHARMASEAL SCRUB CARE at Fusion Pharmaceuticals Inc.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.